Media reports of the cost of new hepatitis C treatments in Australia have largely been low on facts and in some cases big on stigma.Read More
Hepatitis Australia posts news stories relating to viral hepatitis that may be relevant to people living with hepatitis B or C or the people working within the hepatitis health sector. News stories come from both international and Australian sources. Your comments are welcome but any inappropriate comments, or promotional comments will be removed.
Curing hepatitis C and vaccinating against hepatitis B could help drive down liver cancer rates in Australia. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in Australia. HCC most commonly occurs in people with liver disease: particularly in people with chronic hepatitis B and C.Read More
AMA President, Dr Michael Gannon, said today that prevalence of BBVs is significantly higher in prisons, yet custodial facilities provide a unique opportunity to protect the health of inmates.Read More
More new medicines for hepatitis C will continue to become available in 2017 and they will be more effective across a range of hepatitis C genotypes. From 1 January [grazoprevir + elbasvir], given as a once daily tablet, will be available on the PBS and presents a new option for people with genotype 4.Read More
People living with hepatitis C and Healthcare Professionals are advised that direct-acting antiviral (DAA) medicines for the treatment of chronic hepatitis C infection have been associated with reactivation of hepatitis B virus in people with a current or previous hepatitis B infection.Read More